Endocura is a specialized pharmaceutical company that provides innovative cancer prevention and treatment solutions. Endocura is particularly focused on developing localized cancer therapies to improve treatment accuracy and efficiency while minimizing side effects for patients. Our therapies target tumor vasculature instead of the cancer cells themselves, providing an innovative approach to inhibit tumor growth by cutting off their blood supply.
Additionally, we are interested in preventive treatments such as Helicobacter eradication therapy, aiming to contribute to cancer prevention by eliminating Helicobacter pylori infections, a major cause of gastric cancer.